The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 17, 2018

Filed:

Sep. 28, 2012
Applicant:

Chugai Seiyaku Kabushiki Kaisha, Kita-ku, Tokyo, JP;

Inventors:

Tomoyuki Igawa, Shizuoka, JP;

Shinya Ishii, Shizuoka, JP;

Miho Funaki, Shizuoka, JP;

Naoka Hironiwa, Shizuoka, JP;

Shun Shimizu, Shizuoka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); C40B 40/10 (2006.01); C07K 16/28 (2006.01); C07K 16/00 (2006.01); C07K 16/24 (2006.01); C07K 16/26 (2006.01); C07K 16/40 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6854 (2013.01); C07K 16/00 (2013.01); C07K 16/005 (2013.01); C07K 16/24 (2013.01); C07K 16/26 (2013.01); C07K 16/2866 (2013.01); C07K 16/40 (2013.01); G01N 33/6845 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/72 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C40B 40/10 (2013.01);
Abstract

Disclosed is a library consisting essentially of a plurality of antigen-binding molecules differing in sequence from each other, wherein an antigen-binding domain in each of the antigen-binding molecules comprises at least one amino acid residue that changes the antigen-binding activity of the antigen-binding molecule depending on ion concentration conditions. Also disclosed are a composition comprising a plurality of polynucleotide molecules each encoding the antigen-binding molecules, a composition comprising a plurality of vectors each comprising the polynucleotide molecules, a method for selecting the antigen-binding molecules, a method for isolating the polynucleotide molecules, a method for producing the antigen-binding molecules, and a pharmaceutical composition comprising any of the antigen-binding molecules.


Find Patent Forward Citations

Loading…